New Axiron Lawsuit Alleges Testosterone Treatment Caused Deep Vein Thrombosis, Pulmonary Embolism, Bernstein Liebhard LLP Reports

Share Article

The testosterone lawsuit is among hundreds now pending in a federal multidistrict litigation that allege drugs like Axiron, AndroGel and Testim caused men to suffer life-threatening cardiovascular side effects.

Free Case Review
Our Firm is currently evaluating a number of claims on behalf of men who allegedly suffered heart attacks, strokes, and life threatening blood clots due to their use of low testosterone drugs like Axiron.

A new Axiron lawsuit ( has been filed on behalf of a Minnesota man who alleges the testosterone treatment was the cause of a deep vein thrombosis and pulmonary embolism he suffered in 2012, Bernstein Liebhard LLP reports. According to the complaint, which is currently pending in the U.S. District Court, Northern District of Illinois, the Plaintiff was 70 years old when he began using the testosterone gel in April 2012 to treat low testosterone levels, and was hospitalized with the dangerous blood clots in October 2012. He claims that had Eli Lilly & Co. provided adequate warnings about the medication’s association with serious cardiovascular side effects, he would never have used Axiron, or would have had his physician monitor his health more closely.” (Case No. 1:14-cv-08066)

“Our Firm is currently evaluating a number of claims on behalf of men who allegedly suffered heart attacks, strokes, and life threatening blood clots due to their use of low testosterone drugs like Axiron. We are monitoring the growing testosterone litigation with great interest,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now offering free case reviews to victims of heart attacks, strokes, deep vein thrombosis, pulmonary embolism and other life-threatening heart problems that were allegedly caused by prescription testosterone medication.

Testosterone Litigation
According to court documents, this case is just one of hundreds of testosterone lawsuits that are now pending in a multidistrict litigation underway in the Northern District of Illinois. All of these complaints similarly allege that the manufacturers of Axiron, AndroGel, Testim and other low testosterone therapies failed to warn doctors and patients about their potential cardiovascular risks, and concealed those dangers from the public. The lawsuits further allege that the manufacturers of the medications made misleading claims in their promotional materials that convinced many men to seek testosterone therapy, even though they had no real medical need for the treatment. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

Court documents indicate that the litigation involving testosterone treatments has been growing since January 31, 2014, when the U.S. Food & Drug Administration (FDA) launched a safety review of their cardiovascular risks. In September, a panel of outside advisors convened by the FDA recommended that the manufacturers of the medications be required to conduct studies of their cardiovascular side effects. The advisors also recommended that the labeling for low testosterone therapies be revised to make clear they have not been shown to lessen symptoms typically associated with the male aging process, such as low libido and fatigue.*

Men who sustained heart attacks, strokes and other serious heart problems allegedly due to a prescription testosterone drugs may be eligible to receive compensation for damages related to those complications. Learn more about cardiovascular risks potentially associated with prescription testosterone treatments when you visit Bernstein Liebhard LLP’s website, or call 800-511-5092 for a free case review.

*, Reuters, September 18, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website